TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
LobSor Pharmaceuticals AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
87,519
|
11,791
|
36,638 |
| Financial expenses |
0
|
12
|
100 |
| Earnings before taxes |
80,191
|
34,693
|
46,650 |
| EBITDA |
77,335
|
34,044
|
55,549 |
| Total assets |
188,831
|
101,182
|
72,030 |
| Current assets |
156,795
|
69,097
|
32,824 |
| Current liabilities |
92,454
|
15,766
|
740 |
| Equity capital |
96,377
|
85,417
|
71,290 |
| - share capital |
45
|
47
|
49 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
51.0%
|
84.4%
|
99.0% |
| Turnover per employee |
29,173
|
3,930
|
12,213 |
| Profit as a percentage of turnover |
91.6%
|
294.2%
|
127.3% |
| Return on assets (ROA) |
42.5%
|
34.3%
|
64.9% |
| Current ratio |
169.6%
|
438.3%
|
4435.7% |
| Return on equity (ROE) |
83.2%
|
40.6%
|
65.4% |
| Change turnover |
74,891
|
-23,746
|
11,813 |
| Change turnover % |
593%
|
-67%
|
48% |
| Chg. No. of employees |
0
|
0
|
2 |
| Chg. No. of employees % |
0%
|
0%
|
200% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.